封面
市场调查报告书
商品编码
1658704

VNA(供应商中立檔案)和 PACS 全球市场趋势、分析、竞争格局和预测(2019-2031 年),按类型、组件、部署模式、应用、最终用户和地区划分

Vendor Neutral Archive and PACS Market, By Type; By Component; By Deployment Mode; By Application; By End User; By Region, Global Trend Analysis, Competitive Landscape & Forecast, 2019-2031

出版日期: | 出版商: Blueweave Consulting | 英文 525 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球 VNA(供应商中立檔案)和 PACS 市场规模预计将从 2024 年的 43 亿美元成长到 2031 年的 63 亿美元,预测期内的复合年增长率为 5.90%。

影像设备的进步、医疗保健投资的增加以及由于慢性病的流行而导致的医疗程序数量的增加是该市场的主要成长要素。此外,在预测期内,云端储存和主导分析等技术的日益普及也有望推动市场的发展。

商业机会:对数位健康和​​医疗图像的需求不断增加

远端保健等数位医疗技术的日益普及以及对医疗图像的需求不断增长是全球 NVA 和 PACS 市场的主要成长动力。随着医疗保健产业日益数位化,高效储存、搜寻和共用医学影像和病患资料的需求正在激增。影像技术(MRI、 电脑断层扫描、数位X光等)的进步正在增加必须管理的病患资料量。 VNA 允许医疗保健提供者以与供应商无关的格式储存资料,确保系统之间的长期可存取性和互通性。

主导全球 VNA 和 PACS 市场的 VNA 细分市场:

VNA 部门占有最大份额。根据美国国家生物技术资讯中心的一篇论文,使用 VNA 可以在容量基础上降低 30% 以上的储存成本,并将服务和维护成本降低 10% 至 15%。 VNA 可以集中记录患者影像,从而提高医疗机构的整体护理品质并有助于推动市场扩张。

北美占很大份额:

全球 VNA 和 PACS 市场由北美主导。该地区云端储存的使用日益增多以及医学影像资料量的不断增加推动了对完整系统的需求,例如 VNA/PACS 系统,该系统可以储存、管理并提供标准化格式和介面的医学影像的即时存取。然而,预计预测期内亚太地区将以更快的速度扩张。该区域市场的扩张主要受到医疗保健体系的兴起所推动,尤其是在韩国、越南和印度等新兴市场。

本报告调查了全球 VNA(供应商中立檔案)和 PACS 市场,并提供了市场概况摘要、影响市场成长的各种因素分析、技术趋势、法律制度、市场规模趋势和预测、各个细分市场的细分、地区/主要国家、竞争环境以及主要企业的概况。

目录

第一章 调查框架

第 2 章执行摘要

第 3 章 全球 VNA(供应商中立檔案)与 PACS 市场洞察

  • 产业价值链分析
  • DROC 分析
    • 成长动力
    • 限制因素
    • 机会
    • 任务
  • 科技进步/最新趋势
  • 法律规范
  • 波特五力分析

第 4 章 全球 VNA(供应商中立檔案)与 PACS 市场:行销策略

5. 全球 VNA(供应商中立檔案)和 PACS 市场:定价分析

6. 全球 VNA(供应商中立檔案)和 PACS 市场:区域分析

  • 区域分析
  • 市场吸引力分析

7. 全球 VNA (供应商中立檔案) 和 PACS 市场概览

  • 市场规模及预测
  • 市场占有率和预测
    • 按类型
      • 供应商中立檔案 (VNA)
      • 影像存檔与通讯系统 (PACS)
    • 按组件
      • 软体
      • 硬体
      • 服务
    • 依部署方式
      • 本地
      • 杂交种
    • 按应用
      • 放射科
      • 心臟病
      • 整形外科
      • 其他的
    • 按最终用户
      • 医院
      • 诊断中心
      • 研究所
      • 其他的
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 拉丁美洲
      • 中东和非洲

8. 北美 VNA (供应商中立檔案) 和 PACS 市场

  • 市场规模及预测
  • 市场占有率和预测
  • 美国
  • 加拿大

9. 欧洲 VNA (供应商中立檔案) 与 PACS 市场

  • 市场规模及预测
  • 市场占有率和预测
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙
  • 比利时
  • 俄罗斯
  • 荷兰
  • 其他的

10. 亚太地区 VNA (供应商中立檔案) 与 PACS 市场

  • 市场规模及预测
  • 市场占有率和预测
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲和纽西兰
  • 印尼
  • 马来西亚
  • 新加坡
  • 越南
  • 其他的

11. 拉丁美洲 VNA (供应商中立檔案) 与 PACS 市场

  • 市场规模及预测
  • 市场占有率和预测
  • 巴西
  • 墨西哥
  • 阿根廷
  • 秘鲁
  • 其他的

12. 中东和非洲 VNA (供应商中立檔案) 和 PACS 市场

  • 市场规模及预测
  • 市场占有率和预测
  • 沙乌地阿拉伯
  • UAE
  • 卡达
  • 科威特
  • 南非
  • 奈及利亚
  • 阿尔及利亚
  • 其他的

第十三章 竞争格局

  • 主要企业及其产品列表
  • 企业市场占有率分析
  • 竞争性基准化分析:根据业务参数
  • 重大策略发展(併购和联盟)

14. 地缘政治紧张局势加剧对全球 VNA(供应商中立檔案)和 PACS 市场的影响

第 15 章 公司简介(公司概况、财务矩阵、竞争格局、关键人员、主要竞争对手、联繫、策略展望、SWOT 分析)

  • Agfa Healthcare
  • Dell Technologies
  • Fujifilm
  • GE Healthcare
  • IBM
  • Koninklijke Philips
  • Lexmark
  • McKesson
  • Novarad
  • Siemens Healthineers
  • Merge Healthcare
  • Nuance Communications
  • 其他主要企业

第 16 章 关键策略建议

第十七章调查方法

简介目录
Product Code: BWC25064

Global Vendor Neutral Archive (VNA) and PACS Market to Reach USD 6.3 Billion by 2031

Global Vendor Neutral Archive (VNA) and PACS Market is flourishing because of the growing adoption of digital imaging and electronic health records (EHR) in healthcare facilities and a spurring demand for cloud-based VNA solutions.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Global Vendor Neutral Archive (VNA) and PACS Market size at USD 4.3 billion in 2024. During the forecast period between 2025 and 2031, BlueWeave expects Global Vendor Neutral Archive (VNA) and PACS Market size to expand at a CAGR of 5.90% reaching a value of USD 6.3 billion by 2031. Advances in imaging equipment, rising healthcare investment, and the rise in medical procedures due to the prevalence of chronic diseases are major growth factors for Global Vendor Neutral Archive (VNA) and PACS Market. Additionally, the growing adoption of technologies, such as cloud storage and AI-driven analytics, is expected to drive the market over the forecast period.

Opportunity - Increasing Demand for Digital Health and Medical Imaging

The rising adoption of digital health technologies, such as telehealth, and growing demand for medical imaging are emerging as key growth drivers for Global Vendor Neutral Archive (VNA) and PACS Market. With the rising adoption of digitization in the healthcare industry, the need for efficient storage, retrieval, and sharing of medical images and patient data has spiked. The advancements in imaging technologies (like MRI, CT scans, and digital X-rays) have resulted in a rise in the volume of patient data that needs to be managed. VNAs enable healthcare providers to store data in a vendor-neutral format, ensuring long-term accessibility and interoperability across systems.

Impact of Escalating Geopolitical Tensions on Global Vendor Neutral Archive (VNA) and PACS Market

Intensifying geopolitical tensions posed many challenges for Global Vendor Neutral Archive (VNA) and PACS Market. The manufacturing and distribution processes of VNA and PACS systems are hampered by geopolitical instability causing disruptions in the global supply chain. Sanctions or tariffs, for example, prevent the free movement of vital software or components related to VNA and PACS. The adoption or deployment of VNA/PACS systems across the healthcare industry may be slowed down by delays experienced by businesses operating in affected areas, which might raise production and delivery costs. The rise in cyberattacks that target essential infrastructure, particularly healthcare systems, is another significant issue linked to geopolitical tensions on Global Vendor Neutral Archive (VNA) and PACS Market.

VNA Segment Dominates Global VNA and PACS Market

The vendor neutral archive (VNA) segment holds the largest share of Global Vendor Neutral Archive (VNA) and PACS Market. A National Center for Biotechnology Information paper claims that the use of vendor-neutral archives (VNA) reduces storage unit costs by over 30% in terms of volume and service and maintenance costs by 10%-15%. VNAs offer centralized patient-imaging records, which enhances the general quality of care in healthcare facilities and propels the market's expansion.

North America Holds Major Share in Global VNA and PACS Market

North America dominates Global Vendor Neutral Archive (VNA) and PACS Market. The region's growing use of cloud storage and the volume of medical imaging data drive the need for a complete system, such VNA/PACS systems, to store, manage, and offer real-time access to medical images in a standardized format and interface. However, over the forecast period, the APAC area is anticipated to expand at a rapid pace. The regional market's expansion is mostly due to the thriving healthcare system, especially in developing nations like South Korea, Vietnam, and India.

Competitive Landscape

Major companies in Global Vendor Neutral Archive (VNA) and PACS Market include Agfa Healthcare, Dell Technologies, Fujifilm, GE Healthcare, IBM, Koninklijke Philips, Lexmark, McKesson, Novarad, Siemens Healthineers, Merge Healthcare, and Nuance Communications. The presence of high number of companies intensify the market competition as they compete to gain a significant market share. These companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches to further enhance their market share.

The in-depth analysis of the report provides information about growth potential and upcoming trends in Global Vendor Neutral Archive (VNA) and PACS Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Vendor Neutral Archive (VNA) and PACS Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Vendor Neutral Archive (VNA) and PACS Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing Adoption of Digital Imaging and Electronic Health Records (EHR) in Healthcare Facilities
      • 3.2.1.2. Growth in the Demand for Cloud-Based VNA Solutions
      • 3.2.1.3. Rising Need for Interoperability and Consolidation of Medical Imaging Data
    • 3.2.2. Restraints
      • 3.2.2.1. High Initial Investment and Implementation Costs
      • 3.2.2.2. Data Security and Privacy Concerns in Storing Medical Imaging Data
      • 3.2.2.3. Complexity in Integrating VNA with Legacy Healthcare Systems
    • 3.2.3. Opportunities
      • 3.2.3.1. Expansion of Healthcare Services in Emerging Markets
      • 3.2.3.2. Increasing Demand for Scalable, Flexible Storage Solutions
    • 3.2.4. Challenges
      • 3.2.4.1. Ensuring Data Integrity and Seamless Access to Historical Imaging Data
      • 3.2.4.2. Competition from Traditional PACS Solutions and Proprietary Storage Systems
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Vendor Neutral Archive (VNA) and PACS Market: Marketing Strategies

5. Global Vendor Neutral Archive (VNA) and PACS Market: Pricing Analysis

6. Global Vendor Neutral Archive (VNA) and PACS Market: Geographical Analysis

  • 6.1. Global Vendor Neutral Archive (VNA) and PACS Market, Geographical Analysis, 2024
  • 6.2. Global Vendor Neutral Archive (VNA) and PACS Market, Market Attractiveness Analysis, 2024-2031

7. Global Vendor Neutral Archive (VNA) and PACS Market Overview

  • 7.1. Market Size & Forecast, 2019-2031
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
      • 7.2.1.1. Vendor Neutral Archive (VNA)
      • 7.2.1.2. Picture Archiving and Communication System (PACS)
    • 7.2.2. By Component
      • 7.2.2.1. Software
      • 7.2.2.2. Hardware
      • 7.2.2.3. Services
    • 7.2.3. By Deployment Mode
      • 7.2.3.1. Cloud
      • 7.2.3.2. On-premises
      • 7.2.3.3. Hybrid
    • 7.2.4. By Application
      • 7.2.4.1. Radiology
      • 7.2.4.2. Cardiology
      • 7.2.4.3. Oncology
      • 7.2.4.4. Orthopedics
      • 7.2.4.5. Others
    • 7.2.5. By End User
      • 7.2.5.1. Hospitals
      • 7.2.5.2. Diagnostic Centers
      • 7.2.5.3. Research Institutes
      • 7.2.5.4. Others
    • 7.2.6. By Region
      • 7.2.6.1. North America
      • 7.2.6.2. Europe
      • 7.2.6.3. Asia Pacific (APAC)
      • 7.2.6.4. Latin America (LATAM)
      • 7.2.6.5. Middle East and Africa (MEA)

8. North America Vendor Neutral Archive (VNA) and PACS Market

  • 8.1. Market Size & Forecast, 2019-2031
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Component
    • 8.2.3. By Deployment Mode
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
      • 8.2.6.1. United States
      • 8.2.6.1.1. By Type
      • 8.2.6.1.2. By Component
      • 8.2.6.1.3. By Deployment Mode
      • 8.2.6.1.4. By Application
      • 8.2.6.1.5. By End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. By Type
      • 8.2.6.2.2. By Component
      • 8.2.6.2.3. By Deployment Mode
      • 8.2.6.2.4. By Application
      • 8.2.6.2.5. By End User

9. Europe Vendor Neutral Archive (VNA) and PACS Market

  • 9.1. Market Size & Forecast, 2019-2031
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Component
    • 9.2.3. By Deployment Mode
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
      • 9.2.6.1. Germany
      • 9.2.6.1.1. By Type
      • 9.2.6.1.2. By Component
      • 9.2.6.1.3. By Deployment Mode
      • 9.2.6.1.4. By Application
      • 9.2.6.1.5. By End User
      • 9.2.6.2. United Kingdom
      • 9.2.6.2.1. By Type
      • 9.2.6.2.2. By Component
      • 9.2.6.2.3. By Deployment Mode
      • 9.2.6.2.4. By Application
      • 9.2.6.2.5. By End User
      • 9.2.6.3. Italy
      • 9.2.6.3.1. By Type
      • 9.2.6.3.2. By Component
      • 9.2.6.3.3. By Deployment Mode
      • 9.2.6.3.4. By Application
      • 9.2.6.3.5. By End User
      • 9.2.6.4. France
      • 9.2.6.4.1. By Type
      • 9.2.6.4.2. By Component
      • 9.2.6.4.3. By Deployment Mode
      • 9.2.6.4.4. By Application
      • 9.2.6.4.5. By End User
      • 9.2.6.5. Spain
      • 9.2.6.5.1. By Type
      • 9.2.6.5.2. By Component
      • 9.2.6.5.3. By Deployment Mode
      • 9.2.6.5.4. By Application
      • 9.2.6.5.5. By End User
      • 9.2.6.6. Belgium
      • 9.2.6.6.1. By Type
      • 9.2.6.6.2. By Component
      • 9.2.6.6.3. By Deployment Mode
      • 9.2.6.6.4. By Application
      • 9.2.6.6.5. By End User
      • 9.2.6.7. Russia
      • 9.2.6.7.1. By Type
      • 9.2.6.7.2. By Component
      • 9.2.6.7.3. By Deployment Mode
      • 9.2.6.7.4. By Application
      • 9.2.6.7.5. By End User
      • 9.2.6.8. The Netherlands
      • 9.2.6.8.1. By Type
      • 9.2.6.8.2. By Component
      • 9.2.6.8.3. By Deployment Mode
      • 9.2.6.8.4. By Application
      • 9.2.6.8.5. By End User
      • 9.2.6.9. Rest of Europe
      • 9.2.6.9.1. By Type
      • 9.2.6.9.2. By Component
      • 9.2.6.9.3. By Deployment Mode
      • 9.2.6.9.4. By Application
      • 9.2.6.9.5. By End User

10. Asia Pacific Vendor Neutral Archive (VNA) and PACS Market

  • 10.1. Market Size & Forecast, 2019-2031
    • 10.1.1. By Value (USD Billion)
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Component
    • 10.2.3. By Deployment Mode
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
      • 10.2.6.1. China
      • 10.2.6.1.1. By Type
      • 10.2.6.1.2. By Component
      • 10.2.6.1.3. By Deployment Mode
      • 10.2.6.1.4. By Application
      • 10.2.6.1.5. By End User
      • 10.2.6.2. India
      • 10.2.6.2.1. By Type
      • 10.2.6.2.2. By Component
      • 10.2.6.2.3. By Deployment Mode
      • 10.2.6.2.4. By Application
      • 10.2.6.2.5. By End User
      • 10.2.6.3. Japan
      • 10.2.6.3.1. By Type
      • 10.2.6.3.2. By Component
      • 10.2.6.3.3. By Deployment Mode
      • 10.2.6.3.4. By Application
      • 10.2.6.3.5. By End User
      • 10.2.6.4. South Korea
      • 10.2.6.4.1. By Type
      • 10.2.6.4.2. By Component
      • 10.2.6.4.3. By Deployment Mode
      • 10.2.6.4.4. By Application
      • 10.2.6.4.5. By End User
      • 10.2.6.5. Australia & New Zealand
      • 10.2.6.5.1. By Type
      • 10.2.6.5.2. By Component
      • 10.2.6.5.3. By Deployment Mode
      • 10.2.6.5.4. By Application
      • 10.2.6.5.5. By End User
      • 10.2.6.6. Indonesia
      • 10.2.6.6.1. By Type
      • 10.2.6.6.2. By Component
      • 10.2.6.6.3. By Deployment Mode
      • 10.2.6.6.4. By Application
      • 10.2.6.6.5. By End User
      • 10.2.6.7. Malaysia
      • 10.2.6.7.1. By Type
      • 10.2.6.7.2. By Component
      • 10.2.6.7.3. By Deployment Mode
      • 10.2.6.7.4. By Application
      • 10.2.6.7.5. By End User
      • 10.2.6.8. Singapore
      • 10.2.6.8.1. By Type
      • 10.2.6.8.2. By Component
      • 10.2.6.8.3. By Deployment Mode
      • 10.2.6.8.4. By Application
      • 10.2.6.8.5. By End User
      • 10.2.6.9. Vietnam
      • 10.2.6.9.1. By Type
      • 10.2.6.9.2. By Component
      • 10.2.6.9.3. By Deployment Mode
      • 10.2.6.9.4. By Application
      • 10.2.6.9.5. By End User
      • 10.2.6.10. Rest of APAC
      • 10.2.6.10.1. By Type
      • 10.2.6.10.2. By Component
      • 10.2.6.10.3. By Deployment Mode
      • 10.2.6.10.4. By Application
      • 10.2.6.10.5. By End User

11. Latin America Vendor Neutral Archive (VNA) and PACS Market

  • 11.1. Market Size & Forecast, 2019-2031
    • 11.1.1. By Value (USD Billion)
  • 11.2. Market Share & Forecast
    • 11.2.1. By Type
    • 11.2.2. By Component
    • 11.2.3. By Deployment Mode
    • 11.2.4. By Application
    • 11.2.5. By End User
    • 11.2.6. By Country
      • 11.2.6.1. Brazil
      • 11.2.6.1.1. By Type
      • 11.2.6.1.2. By Component
      • 11.2.6.1.3. By Deployment Mode
      • 11.2.6.1.4. By Application
      • 11.2.6.1.5. By End User
      • 11.2.6.2. Mexico
      • 11.2.6.2.1. By Type
      • 11.2.6.2.2. By Component
      • 11.2.6.2.3. By Deployment Mode
      • 11.2.6.2.4. By Application
      • 11.2.6.2.5. By End User
      • 11.2.6.3. Argentina
      • 11.2.6.3.1. By Type
      • 11.2.6.3.2. By Component
      • 11.2.6.3.3. By Deployment Mode
      • 11.2.6.3.4. By Application
      • 11.2.6.3.5. By End User
      • 11.2.6.4. Peru
      • 11.2.6.4.1. By Type
      • 11.2.6.4.2. By Component
      • 11.2.6.4.3. By Deployment Mode
      • 11.2.6.4.4. By Application
      • 11.2.6.4.5. By End User
      • 11.2.6.5. Rest of LATAM
      • 11.2.6.5.1. By Type
      • 11.2.6.5.2. By Component
      • 11.2.6.5.3. By Deployment Mode
      • 11.2.6.5.4. By Application
      • 11.2.6.5.5. By End User

12. Middle East and Africa Vendor Neutral Archive (VNA) and PACS Market

  • 12.1. Market Size & Forecast, 2019-2031
    • 12.1.1. By Value (USD Billion)
  • 12.2. Market Share & Forecast
    • 12.2.1. By Type
    • 12.2.2. By Component
    • 12.2.3. By Deployment Mode
    • 12.2.4. By Application
    • 12.2.5. By End User
    • 12.2.6. By Country
      • 12.2.6.1. Saudi Arabia
      • 12.2.6.1.1. By Type
      • 12.2.6.1.2. By Component
      • 12.2.6.1.3. By Deployment Mode
      • 12.2.6.1.4. By Application
      • 12.2.6.1.5. By End User
      • 12.2.6.2. UAE
      • 12.2.6.2.1. By Type
      • 12.2.6.2.2. By Component
      • 12.2.6.2.3. By Deployment Mode
      • 12.2.6.2.4. By Application
      • 12.2.6.2.5. By End User
      • 12.2.6.3. Qatar
      • 12.2.6.3.1. By Type
      • 12.2.6.3.2. By Component
      • 12.2.6.3.3. By Deployment Mode
      • 12.2.6.3.4. By Application
      • 12.2.6.3.5. By End User
      • 12.2.6.4. Kuwait
      • 12.2.6.4.1. By Type
      • 12.2.6.4.2. By Component
      • 12.2.6.4.3. By Deployment Mode
      • 12.2.6.4.4. By Application
      • 12.2.6.4.5. By End User
      • 12.2.6.5. South Africa
      • 12.2.6.5.1. By Type
      • 12.2.6.5.2. By Component
      • 12.2.6.5.3. By Deployment Mode
      • 12.2.6.5.4. By Application
      • 12.2.6.5.5. By End User
      • 12.2.6.6. Nigeria
      • 12.2.6.6.1. By Type
      • 12.2.6.6.2. By Component
      • 12.2.6.6.3. By Deployment Mode
      • 12.2.6.6.4. By Application
      • 12.2.6.6.5. By End User
      • 12.2.6.7. Algeria
      • 12.2.6.7.1. By Type
      • 12.2.6.7.2. By Component
      • 12.2.6.7.3. By Deployment Mode
      • 12.2.6.7.4. By Application
      • 12.2.6.7.5. By End User
      • 12.2.6.8. Rest of MEA
      • 12.2.6.8.1. By Type
      • 12.2.6.8.2. By Component
      • 12.2.6.8.3. By Deployment Mode
      • 12.2.6.8.4. By Application
      • 12.2.6.8.5. By End User

13. Competitive Landscape

  • 13.1. List of Key Players and Their Offerings
  • 13.2. Global Vendor Neutral Archive (VNA) and PACS Company Market Share Analysis, 2024
  • 13.3. Competitive Benchmarking, By Operating Parameters
  • 13.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)

14. Impact of Escalating Geopolitical Tensions on Global Vendor Neutral Archive (VNA) and PACS Market

15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 15.1. Agfa Healthcare
  • 15.2. Dell Technologies
  • 15.3. Fujifilm
  • 15.4. GE Healthcare
  • 15.5. IBM
  • 15.6. Koninklijke Philips
  • 15.7. Lexmark
  • 15.8. McKesson
  • 15.9. Novarad
  • 15.10. Siemens Healthineers
  • 15.11. Merge Healthcare
  • 15.12. Nuance Communications
  • 15.13. Other Prominent Players

16. Key Strategic Recommendations

17. Research Methodology

  • 17.1. Qualitative Research
    • 17.1.1. Primary & Secondary Research
  • 17.2. Quantitative Research
  • 17.3. Market Breakdown & Data Triangulation
    • 17.3.1. Secondary Research
    • 17.3.2. Primary Research
  • 17.4. Breakdown of Primary Research Respondents, By Region
  • 17.5. Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable